Skip to main content
Home
Conference
Agenda
Registration
Abstract Guidelines & FAQs
Venue & Accommodations
Next-Generation Travel Award
Totally RAD Award
Patient-Case Studies
Sponsors
Sponsorship Opportunites
Education & Resources
Articles & Publications
Past Conferences
About
Contact
Home
Conference
Agenda
Registration
Abstract Guidelines & FAQs
Venue & Accommodations
Next-Generation Travel Award
Totally RAD Award
Patient-Case Studies
Sponsors
Sponsorship Opportunites
Education & Resources
Articles & Publications
Past Conferences
About
Contact
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 2a Study to Evaluate the Mechanism of Action of Abrocitinib Monotherapy for Moderate-to-Severe Atopic Dermatitis (JADE MOA)